Syncom Formulations (India) Ltd - SYNCOM FORMUL. Share Price

Sector: Pharmaceuticals | ISIN: INE312C01025
₹ 12.70 (3.25%) icon16 Apr, 2024, 12:00:00 AM

Syncom Formulations (India) Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 4/16/2024 12:00:00 AM

    ₹ 12.7 0.40 3.25
  • Open
  • ₹ 12.1
  • Prev. Close
  • ₹ 12.3
  • Turnover(Lac.)
  • ₹ 121
  • Day's High
  • ₹ 12.8
  • Day's Low
  • ₹ 12
  • 52 Week's High
  • ₹ 18.65
  • 52 Week's Low
  • ₹ 5.9
  • Book Value
  • ₹ 2.9
  • Face Value
  • ₹ 1
  • Mkt Cap (₹ Cr.)
  • 1,193.8
  • P/E
  • 46.85
  • EPS
  • 0.27
  • Divi. Yield
  • 0

Syncom Formulations (India) Ltd Corporate Actions

06 Feb , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

06 Feb , 2024

12:00 AM

27 Oct , 2023

12:00 AM

27 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

14 Aug , 2023

12:00 AM

AGM

Announcement date: 14 Aug , 2023

View Details

03 Aug , 2023

12:00 AM

03 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

20 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

20 May , 2023

12:00 AM

02 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

16 Aug , 2023

12:00 AM

BookCloser

View Details

No Record Found


Syncom Formulations (India) Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Syncom Formulations (India) Ltd SHAREHOLDING SNAPSHOT
18 April , 2024 | 07:03 AM

ad IconAd Image

Syncom Formulations (India) Ltd FINANCIALS

No Data Available To Display Chart

Syncom Formulations (India) Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Syncom Formulations (India) Ltd

  • Kedarmal Bankda
  • Chairman & Wholetime Director
  • Vijay Shankarlal Bankda
  • Managing Director
  • Vinod Kumar Kabra
  • Independent Director
  • Krishna Das Neema
  • Independent Director
  • Praveen Jindal
  • Independent Director
  • Rinki Bankda
  • Whole-time Director
  • Ruchi Jindal
  • Independent Director
  • Vaishali Agrawal
  • Company Sec. & Compli. Officer
  • Ritesh Kumar Lunkad
  • Independent Director
  • Ankit Jain
  • Independent Director

Summary

Summary Info Not Found


Reports by Syncom Formulations (India) Ltd


Reports by Syncom Formulations (India) Ltd

Company FAQ

No Record Found